Munich-based Symphera, a medical device startup, announced on Monday, that it has secured €2.4M in a seed financing round led by High-Tech Gründerfonds (HTGF).
The round was led by HTGF with participation from Bayern Kapital, CARMA FUND, UnternehmerTUM Funding for Innovators, Stern Stewart Ventures, IRCAD, and expert business angels.
The German company will use the funds to advance the development of its product, and conduct initial pre-clinical tests to initiate the preparation for the certification process.
Symphera: Streamlining surgical procedures
Founded in 2023, Symphera was incubated at TU Munich and UnternehmerTUM, originating from the University Hospital in Basel.
The company develops advanced surgical systems for laparoscopic procedures that automate tool-switching.
The company’s technology makes manual instrument changes obsolete.
With the push of a button, surgeons can seamlessly switch between instruments, much like using a multipen, allowing them to maintain full focus throughout the whole procedure.
The goal is to simplify surgical workflows, reduce the operating time, and improve patient post-operative outcomes.
The investor
HTGF is an active early-stage investor in Germany and Europe, financing startups in Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences, and Chemistry.
The VC invests in pre-seed and seed phases and participates significantly in later-stage financing rounds.
With over €2B under management, HTGF has financed more than 750 startups and successfully sold shares in more than 180 companies.
Dr. Jan Engels, Investment Manager at HTGF, says “With its surgical tool, Symphera addresses the entire spectrum of laparoscopy, from improving the standard workflow to robot-assisted applications, making Symphera a strong venture case in a highly interesting field.”
Prof. Jacques Marescaux, Founder and President of IRCAD says, “At IRCAD, we are always on the lookout for innovations that can reshape the landscape of minimally invasive surgery. Symphera’s approach to automating tool-switching is not only innovative—it’s revolutionary. We are excited to support them in bringing this technology to the operating rooms worldwide.”
